GP
Insider
Gautam Patel
DirectorGautam Patel (Director) filed 7 Form 4 reports in the past 24 months (0 purchases, 7 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $761K of AMRX (94,906 sh × $8.02, as filed), executed Jun 16 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.9M
shares × price, as filed
Last traded
Jun 16 2025
Filed Jun 18 2025
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 24 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 7 sells
7 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$761K94,906 sh × $8.02
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $453K
56,426 sh × $8.02
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $664K
80,000 sh × $8.30
Exec Apr 1 2025
Filed Apr 2 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $712K
80,000 sh × $8.90
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $651K
80,000 sh × $8.14
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $501K
62,590 sh × $8.01
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $139K
17,410 sh × $8.01
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET